Read more

All materials related to the From Testing to Targeted Treatment Programme

People

Geraldine Reilly

Global Patient Engagement lead Gilead Science at Gilead Sciences

United Kingdom

Gilead Sciences

Nicola Bedlington

Secretary General at European Patients' Forum

Brussels, Belgium

Quentin Clermont

COO at The Synergist

The Synergist

Nicholas Brooke

PFMD Executive Director

Bruxelles, Belgium

The Synergist

Pledge icon

Nicole Wicki

Program Manager at The Synergist

Switzerland

The Synergist / From Testing to Targeted Treatments (FT3)

Silvia Bornengo

Program Coordinator

The Synergist / From Testing to Targeted Treatments (FT3)

Rebecca Vermeulen

Head Global Medical Liaisons and Communications

F. Hoffmann La Roche

Marc Boutin

Global Head of Patient Engagement & Advocacy

United States

Novartis

Sanja Njegic

Global Head Patient Partnership

F. Hoffmann La Roche

DW

Durhane Wong-Rieger

President & CEO

Toronto, Canada

Canadian Organization for Rare Disorders / From Testing to Targeted Treatments (FT3)

Organizations

International Consortium for Personalised Medicine

Multistakeholder alliance

Initiatives

  From Testing to Targeted Treatments (FT3) Program

Resources

The Immuno-oncology Portal (IOP)

21 Jan 2021 Learning and training

More then a number - Better health begins with you

14 Dec 2020 Publication

Roche Personalised Healthcare Small differences, big effects

14 Dec 2020 Publication

What is personalised healthcare in cancer care?

14 Dec 2020 Publication

What you need to know about biomarker testing

14 Dec 2020 Framework/guidance

Personalised Medicine: A Guide for Patients

30 Nov 2020 Fact sheet

PEOF 2020 slides - From diagnosis to treatment and beyond: personalized medicine – what’s in it for patients and understanding patient needs to make it a reality?

29 Sep 2020 Other

Personalised Medicine

24 Aug 2020 Article and blog post

What is Personalised Medicine

24 Aug 2020 Article and blog post

Improving outcomes through Personalised Medicine: working at the cutting edge of science to improve patients' lives

24 Aug 2020 Publication

The age of Personalized Medicine: What is Personalized Medicine?

24 Aug 2020 Fact sheet

The case for Personalized Medicine

24 Aug 2020 Publication

The Evolution of Biomarker use in Clinical Trials for Cancer Treatments: Key findings and implications

24 Aug 2020 Publication

Personalized Medicine at FDA: The Scope & Significance of Progress in 2019

24 Aug 2020 Publication

The Personalized Medicine Report: 2017 Opportunities, challenges and future

24 Aug 2020 Research report

A Consumer's Guide to Genetic Health Testing

14 Aug 2020 Framework/guidance

What is personalised healthcare in cancer care?

14 Aug 2020 Framework/guidance

Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.

14 Aug 2020 Publication

Precision or Personalized Medicine

14 Aug 2020 Article and blog post